The Olink Analysis Service labs in Uppsala and Boston are now able to receive SARS-CoV-2 infected samples, regardless of sample type, and process them without inactivation.
This decision has been made based on the review of US and Sweden governmental regulations and scientific literature, as well as a thorough review of our processes and safety precautions in our labs.